Full-Time

Quality Operations Manager/Sr Manager

Confirmed live in the last 24 hours

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulators for medical conditions

Biotechnology
Healthcare

Compensation Overview

$150.2k - $215.6kAnnually

Senior, Expert

San Carlos, CA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Strong technical knowledge of analytical chemistry and pharmaceutical manufacturing technologies and processes
  • Strong experience with executed batch record review and in-depth knowledge of quality and regulatory requirements for the release of pharmaceutical products
  • Ability to work independently and communicate effectively with project team members and management groups and suppliers
  • Work well in a project team environment with solid problem analysis and decision-making ability
  • Ability to lead or support internal and external compliance audits of suppliers, CTLs, and CMOs
  • Ability to work independently in addition to clearly and concisely communicate both in writing and verbally
  • Ability to identify compliance risk and recommend mitigations
  • Ability to author, review, and approve SOPs and other controlled documentation for compliance with applicable regulations
  • Strong statistical mindset and metric presentation
  • Proficient computer skills are needed with experience using Microsoft Word, Excel, PowerPoint, and Visio
  • BS or MS degree in science, engineering or related field
  • At least 10 years in the bio/pharmaceutical industry
  • At least 5-10 years in Quality Assurance
  • Knowledge in application of 21CFR211, global cGMP regulations, and ICH guidelines regarding good manufacturing practices in the development, manufacturing, testing, delivery, and control of pharmaceutical products
Responsibilities
  • Lead QA operations oversight of Corcept and external partners processes to support various Chemistry, Manufacturing and Controls (CMC) projects
  • Provide cGMP compliance support and guidance to cross functional team
  • Work cross-functionally with the CMC group to provide oversight and support and manage review and approvals of change controls, deviations, CAPAs, and SOPs internally and externally
  • Review and approve Master Batch Record (MBR) and executed batch records (EBR) and test data, and perform product disposition in compliance with cGMP regulations, regulatory filings, and quality agreements
  • Review and approval of validation protocols and reports (e.g., process, method, cleaning, etc.)
  • Lead and support supplier qualification
  • Perform regular update of Quality Agreements
  • Perform quality trends analysis and reports, recommending continual improvements opportunities

Corcept Therapeutics focuses on developing treatments that regulate cortisol, a hormone important for stress response, metabolism, and immune function. Their main product, Korlym, is the first FDA-approved treatment for Cushing's syndrome, a condition caused by excessive cortisol. The company has discovered over 1,000 selective cortisol modulators and aims to expand its offerings with new treatments in development. Unlike many competitors, Corcept emphasizes both research and patient education, providing resources to improve understanding and care for cortisol-related conditions. The goal of Corcept is to advance the treatment of serious medical conditions linked to cortisol imbalance.

Company Stage

IPO

Total Funding

$42.6M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

23%

1 year growth

31%

2 year growth

53%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant investments from firms like Intrinsic Edge Capital and Jackson Creek Investment Advisors indicate strong market confidence in Corcept's growth potential.
  • The appointment of experienced leaders like Roberto Vieira and Monica Tellado suggests a strategic focus on expanding into oncology and emerging markets.
  • Corcept's commitment to patient and medical education enhances its reputation and fosters better patient outcomes.

What critics are saying

  • Ongoing legal disputes, such as the antitrust lawsuit from Teva, could result in financial and operational setbacks.
  • The loss of the Korlym patent lawsuit to Teva poses a significant threat to Corcept's revenue stream from its flagship product.

What makes Corcept Therapeutics unique

  • Corcept Therapeutics specializes exclusively in cortisol modulation, setting it apart from broader-focused biopharmaceutical companies.
  • Their flagship product, Korlym, is the first FDA-approved treatment for hypercortisolism in Cushing's syndrome, giving them a unique market position.
  • Corcept's extensive R&D pipeline with over 1,000 discovered selective cortisol modulators highlights their commitment to innovation in this niche field.

Help us improve and share your feedback! Did you find this helpful?